Sebetralstat for On-demand Treatment of Hereditary Angioedema Attacks: Results of the Double-blind, Placebo-controlled, Phase 3 KONFIDENT Trial

Reidl MA, Aygören-Pürsün E, Lumry WR, Farkas H, Zanichelli A, Hao J, Iverson M, Smith MD, Yea CM, Audhya PK, Bernstein JA, Maurer M, Cohn DM

CIIC 2024

Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema

Feener EP, Davie RL, Murugesan N, Pethen SJ, Hampton SL, Smith MD, Audhya PK, Yea CM

Drugs and Drug Candidates

Relationship Between Time to On-demand Treatment and Quality of Life During Hereditary Angioedema Attacks

Christiansen S, Craig T, O’Connor M, Radojicic C, Ulloa J, Danese S, Desai V, Andriotti T, Audhya P, Busse P

2024 HAEi Regional Conference

Delayed On-Demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers

Christiansen S, O’Connor M, Ulloa J, Danese S, Desai V, Audhya P, Busse P

2024 HAEi Regional Conference

Characterizing the Negative Impact of Delayed On-Demand Treatment of HAE Attacks

Ogbogu P, Longhurst H, van Kooten S, Malloy N, Heckmann M, Ulloa J, Zwiener R

2024 HAEi Regional Conference

Anxiety Associated with Refilling On-demand Therapy for HAE Attacks Contributes to Treatment Delay and Non-Treatment

Soteres DF, Grumach AS, van Kooten S, Malloy N, Heckmann M, Ulloa J, Burnette A

2024 HAEi Regional Conference

Characteristics of Hereditary Angioedema Attacks Among Long-Term Prophylaxis Users

Geng B, Desai V, Ulloa J, Danese S, Audhya P, Craig T

2024 HAEi Regional Conference

Treatment Patterns of Patients Requiring Redosing of an On-demand Treatment After the Return of an HAE Attack

Katelaris C, Manning M, van Kooten S, Malloy N, Heckmann M, Ulloa J, Lumry W

2024 HAEi Regional Conference

Anxiety Associated with On-Demand Treatment for Hereditary Angioedema (HAE) Attacks

Wedner J, Radojicic C, Ulloa J, Danese S, Desai V, Audhya P, Christiansen S

2024 HAEi Regional Conference

POSTER & SUPPLEMENT: Sebetralstat for On-demand Treatment of Hereditary Angioedema Attacks: Results of the Double-blind, Placebo-controlled Phase 3 KONFIDENT Trial

Marc A. Riedl, Emel Aygören-Pürsün, William R. Lumry, Henriette Farkas, Andrea Zanichelli, James Hao, Matthew Iverson, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, Jonathan A. Bernstein, Marcus Maurer, Danny M. Cohn

AAAAI 2024